Neurochemistry
Showing 26 - 50 of 96
Attention Deficit Disorder With Hyperactivity Trial in Kfar Saba, Re?ovot (Neurotransmitters evaluation by MRS)
Not yet recruiting
- Attention Deficit Disorder With Hyperactivity
- Neurotransmitters evaluation by MRS
-
Kfar Saba, Israel
- +1 more
Jul 14, 2022
Alzheimer Trial in Worldwide (Gantenerumab, Placebo)
Active, not recruiting
- Alzheimer Disease
- Gantenerumab
- Placebo
-
Phoenix, Arizona
- +156 more
Jul 4, 2022
Depression, Dual Diagnosis, Drug Addiction Trial in Salt Lake City (Creatine monohydrate)
Recruiting
- Depression
- +2 more
- Creatine monohydrate
-
Salt Lake City, UtahUniversity of Utah
Nov 2, 2020
Eating Disorders : Food Craving and Addiction Transfer
Recruiting
- Substance Use Disorders
- Eating Disorders
- Questionnaire
-
Bordeaux, Gironde, FranceCentre Hospitalier Universitaire de Bordeaux
May 6, 2022
Magnetic Resonance Imaging of Neuropsychiatric Patients and
Recruiting
- Schizophrenia
- Normal Physiology
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
The Longitudinal Study of Stimulant Use Disorder
Not yet recruiting
- Stimulant Use
- +2 more
-
Dallas, TexasUT Southwestern Medical Center
Oct 3, 2023
Visual Impairment, Low Vision, Depression Trial in Cambridge (Mindful Music Listening, Music Listening)
Recruiting
- Visual Impairment
- +5 more
- Mindful Music Listening
- Music Listening
-
Cambridge, United KingdomDepartment of Vision and Hearing Sciences
May 13, 2022
Neurodegeneration in Brain and Spinal Cord in Friedreich's
Active, not recruiting
- Friedreich Ataxia
-
Minneapolis, MinnesotaUniversity of Minnesota
Mar 3, 2022
Subarachnoid Hemorrhage, Brain Ischemia, Subarachnoid Hemorrhage, Aneurysmal Trial in Mexico City (Dapsone, Aluminum Hydroxide
Completed
- Subarachnoid Hemorrhage
- +5 more
- Dapsone
- Aluminum Hydroxide Gel
-
Mexico City, MexicoEl Instituto Nacional de Neurologia y Neurocirugia Manuel Velasc
Nov 10, 2021
Depressive Disorder, Treatment-Resistant Trial in Oxford (Ebselen, Placebo)
Recruiting
- Depressive Disorder, Treatment-Resistant
- Ebselen
- Placebo
-
Oxford, Oxfordshire, United KingdomNeurosciences Building, Dept. Psychiatry, Warneford Hospital
Dec 15, 2021
Autism Trial (Improvisational Music Therapy)
Not yet recruiting
- Autism
- Improvisational Music Therapy
- (no location specified)
Aug 31, 2023
Nicotine and Brain Imaging Research Study
Completed
- Nicotine
-
Philadelphia, PennsylvaniaPenn Center for Women's Behavioral Wellness, University of Penns
Aug 3, 2021
Anxiety, Depression Trial in London (High-EPA multinutrient supplement., Placebo)
Recruiting
- Anxiety
- Depression
- High-EPA multinutrient supplement.
- Placebo
-
London, United KingdomUniversity of Roehampton
May 12, 2022
Langerhans Cell Histiocytosis Trial in United States (drug, procedure, biological)
Recruiting
- Langerhans Cell Histiocytosis
- Prednisone
- +8 more
-
Birmingham, Alabama
- +35 more
Feb 17, 2022
Brain Tumors, Radiotherapy Trial in Poznan (Exercise treatment)
Recruiting
- Brain Tumors
- Radiotherapy
- Exercise treatment
-
PoznaĆ, Greater Poland, PolandGreater Poland Cancer Centre
Dec 30, 2021
Sports Injury, Intermittent Fasting Trial in Bloomington (Soccer Heading, Intermittent Fasting)
Recruiting
- Sports Injury
- Intermittent Fasting
- Soccer Heading
- Intermittent Fasting
-
Bloomington, IndianaIndiana University School of Public Health
Feb 1, 2022
Tinnitus, Hearing Loss Trial in Nottingham (MRI scanning)
Recruiting
- Tinnitus
- Hearing Loss
- MRI scanning
-
Nottingham, United Kingdom
- +2 more
May 20, 2022
Cocaine Dependence Trial in Belmont (Lorcaserin, Placebo Oral Tablet)
Unknown status
- Cocaine Dependence
- Lorcaserin
- Placebo Oral Tablet
-
Belmont, MassachusettsMcLean Hospital
Feb 22, 2021
Tourette Syndrome, Tardive Dyskinesia Trial in Houston (Pimavanserin)
Completed
- Tourette Syndrome
- Tardive Dyskinesia
-
Houston, TexasBaylor College of Medicine
Mar 10, 2021
Brain Neurochemical Profile During Marijuana Abstinence
Completed
- Brain Metabolic Changes During Marijuana Abstinence
- abstinence from use of marijuana and other abused drugs
-
Belmont, MassachusettsChun Zuo
Mar 24, 2020
MDD Trial in Los Angeles (Placebo, intermittent theta burst stimulation, intravenous citalopram HCl (CIT))
Active, not recruiting
- Major Depressive Disorder
- Placebo
- +3 more
-
Los Angeles, CaliforniaUCLA Depression Research and Clinic Program
May 17, 2022
Parkinson Disease Trial in Portland (Donepezil, Placebo)
Completed
- Parkinson Disease
- Donepezil
- Placebo
-
Portland, OregonOregon Health & Science University
May 8, 2020
MDD Trial in Los Angeles (Ketamine)
Completed
- Major Depressive Disorder
-
Los Angeles, CaliforniaGeffen School of Medicine, UCLA
Aug 27, 2019
Brain Tissue Collection for Neuropathological Studies
Terminated
- Bipolar Disorder
- +5 more
-
Washington, District of Columbia
- +2 more
Dec 6, 2019